17 US companies filed quarterly results with the SEC (8-K Item 2.02). We read every one and called the likely one-week price move. Calls are graded in the open.
The appointment of a new CFO with public company experience may strengthen the executive leadership team, but the filing lacks quantified surprises, and the announcement of fourth quarter and fiscal 2026 results is separate and not detailed in this 8-K.
OUR ANALYSIS → VIEW 8-K →Penguin Solutions reported record results across key financial metrics, with net sales up 68% year over year and diluted EPS up 1,073% year over year, also raising its fiscal 2027 outlook, but the announcement includes a $750 million convertible senior notes offering, which implies dilution
OUR ANALYSIS → VIEW 8-K →BioMarin expects to incur approximately $283 million in pre-tax charges related to the acquisition of Alesta Therapeutics, resulting in an unfavorable impact of $1.50 to both GAAP and Non-GAAP Diluted EPS for the third quarter of 2026. The acquisition is expected to result in total pre-tax charges of approximately $320 million for the full year 2026, representing an unfavorable impact of $1.55 to
OUR ANALYSIS → VIEW 8-K →Bridgeline Digital reports record quarterly and annual sales for its HawkSearch AI eCommerce platform, with $1.4M in TCV and $400K in ARR from 12 new customers in the fourth quarter, and $8M in TCV and $2.2M in ARR from 38 new customers in fiscal 2026, demonstrating strong growth momentum.
OUR ANALYSIS → VIEW 8-K →Lamb Weston reported Q1 fiscal 2027 results with net sales increasing 1% year-over-year to $1.67 billion, and adjusted diluted EPS of $0.75, while also increasing its full-year 2027 outlook for net sales, adjusted diluted EPS, and adjusted EBITDA. The company's North America segment drove growth, with a 5% increase in net sales and an 11% increase in segment adjusted EBITDA, offset by a decline in
OUR ANALYSIS → VIEW 8-K →Apogee Enterprises reported a 9.2% increase in net sales and raised its fiscal 2027 adjusted diluted EPS guidance range, driven by strong execution and the benefits of disciplined pricing and productivity initiatives. The company's acquisition of Kalwall and Groglass is expected to further strengthen its portfolio and support long-term value creation.
OUR ANALYSIS → VIEW 8-K →HubSpot is undergoing a restructuring plan that will eliminate approximately 7% of its workforce, resulting in estimated charges of $65-75 million, which will be excluded from non-GAAP financial measures. The company expects to recognize the majority of these charges in the fourth quarter of fiscal year 2026.
OUR ANALYSIS → VIEW 8-K →Figure Technology Solutions reported preliminary Q3 operating data at the high end of guidance, with Consumer Loan Marketplace Volume of $5.119B, a 20% Q/Q increase and 107% Y/Y increase, but this is unaudited and preliminary, subject to revision in final quarterly filings
OUR ANALYSIS → VIEW 8-K →AXIL Brands reported an 11.2% decrease in net revenues for the first fiscal quarter, but showed improvements in gross profit and net income, with a strong launch of XCOR II generating orders exceeding $3.6 million, which is expected to reflect in second quarter revenue
OUR ANALYSIS → VIEW 8-K →Constellation Brands reported a 25% increase in EPS and a 6% increase in net sales, with the beer business delivering net sales and operating income growth, but the release lacks specific quantified surprises beyond the earnings report, which may already be priced in.
OUR ANALYSIS → VIEW 8-K →This 8-K filing is an announcement of Golub Capital BDC, Inc.'s upcoming earnings release and conference call, with no quantified surprises or material updates, so it's unlikely to impact the stock price significantly.
OUR ANALYSIS → VIEW 8-K →AMASS Brands Inc. reported preliminary third-quarter net revenue of approximately $5.3 million, exceeding guidance by 20% and representing a 30% year-over-year increase, driven by strong growth in core brand and non-alcoholic & functional revenue
OUR ANALYSIS → VIEW 8-K →Saratoga Investment Corp. reported fiscal second quarter 2027 results with 2.1% asset growth and $37.1 million in net originations, but NAV per share declined due to company-specific valuation adjustments and dividend distributions exceeding net investment income. The company's share repurchases and recent sales of non-accrual investments are positives, but may not be enough to offset the decline
OUR ANALYSIS → VIEW 8-K →Neogen Corp reported a 6.5% revenue growth to $222.8 million and raised fiscal year 2027 financial guidance for revenue and Adjusted EBITDA, indicating a positive surprise
OUR ANALYSIS → VIEW 8-K →SHF Holdings, Inc. reports preliminary third quarter 2026 deposit results with a 7.4% year-over-year increase and expects to benefit from higher interest rates, estimating an additional $150,000 in annualized investment income
OUR ANALYSIS → VIEW 8-K →Regeneron receives a $1 billion upfront payment and is eligible for up to $7 billion in additional milestone payments from Sanofi for co-developing and co-commercializing four new antibodies, with global profits to be shared equally between the two companies. This collaboration is a significant positive development for Regeneron, with substantial potential future payments.
OUR ANALYSIS → VIEW 8-K →RPM International Inc. reported record fiscal 2027 first-quarter results with sales of $2.22 billion, a 4.8% increase from the prior year, and record adjusted diluted EPS of $1.98, a 5.3% increase. The company's fiscal 2027 second-quarter and full-year outlook projects sales and adjusted EBITDA to increase in the low- to mid-single-digit range and mid-single-digit range, respectively.
OUR ANALYSIS → VIEW 8-K →The material filings, RNS and EU notices in one email every market day, read and scored by AI.
Subscribe free →Oct 7 (3) · Oct 5 (17) · Oct 2 (7) · Oct 1 (13) · Sep 30 (14) · Sep 29 (8) · Sep 28 (8) · Sep 25 (5) · Sep 24 (11) · Sep 23 (7) · Sep 22 (6) · Sep 21 (4) · Sep 18 (8) · Sep 17 (3) · Sep 16 (3) · Sep 15 (7) · Sep 14 (11) · Sep 11 (13) · Sep 10 (18) · Sep 9 (27)